BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6639096)

  • 1. [Effect of C-reactive protein on natural killer activity].
    Shibuya M; Saijo N; Shimizu E; Taniguchi T; Takizawa T; Fujioka H; Hoshi A
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2341-6. PubMed ID: 6639096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of surgical treatment on the natural killer activity in lung cancer patients].
    Ancheva M; Boeva M; Tenev V
    Eksp Onkol; 1989; 11(2):39-41. PubMed ID: 2737129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C-reactive protein inhibits cytoskeletal rearrangement without altering calcium influx in natural killer cell activation.
    Khattri R; Hansen B; Nichols TC; Palmer KL; Gilman-Sachs A; Baum LL
    Cell Immunol; 1994 May; 155(2):457-75. PubMed ID: 8181076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the decreased NK (natural killer) activity in lung cancer patients, using whole blood versus separated mononuclear cells.
    Nielsen LR; Kimose HH; Linnet L; Møller NP; Bukh A
    J Clin Lab Immunol; 1989 Jun; 29(2):71-7. PubMed ID: 2632804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice.
    Nokihara H; Yanagawa H; Nishioka Y; Yano S; Mukaida N; Matsushima K; Sone S
    Cancer Res; 2000 Dec; 60(24):7002-7. PubMed ID: 11156403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice.
    Spitzer JH; Núñez NP; Meadows SA; Gallucci RM; Blank SE; Meadows GG
    Alcohol Clin Exp Res; 2000 Jun; 24(6):837-44. PubMed ID: 10888072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of CDDP administration on NK activity of human peripheral lymphocytes and its modification by corticosteroid as anti-emetic agent].
    Takahashi K; Saijo N; Seki S; Kimata M; Sasaki Y; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Hoshi A
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):492-6. PubMed ID: 6538405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study of a multiregression analysis on the NK activity and related clinical factors in patients with lung cancer].
    Ogata H; Miyoshi T; Itami J; Anzai Y; Yoshikawa K; Takizawa Y; Takano H; Yamada T; Terauchi T; Saito M
    Gan No Rinsho; 1989 Apr; 35(5):554-9. PubMed ID: 2716187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanol and natural killer cells. II. Stimulation of human natural killer activity by ethanol in vitro.
    Li F; Cook RT; Alber C; Rasmussen W; Stapleton JT; Ballas ZK
    Alcohol Clin Exp Res; 1997 Sep; 21(6):981-7. PubMed ID: 9309305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant drugs increase natural killer cell activity in lung cancer.
    Bobek V; Boubelik M; Fiserová A; L'uptovcová M; Vannucci L; Kacprzak G; Kolodzej J; Majewski AM; Hoffman RM
    Lung Cancer; 2005 Feb; 47(2):215-23. PubMed ID: 15639720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases.
    Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K
    Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
    Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
    Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce postoperative metastasis.
    Shakhar G; Abudarham N; Melamed R; Schwartz Y; Rosenne E; Ben-Eliyahu S
    Ann Surg Oncol; 2007 Feb; 14(2):841-52. PubMed ID: 17091332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells.
    Clayman GL; Taylor DL; Liu FJ; Lavedan P; Savage HE; Schantz SP
    Laryngoscope; 1993 Mar; 103(3):299-307. PubMed ID: 7680086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.
    Saijo N; Shimizu E; Irimajiri N; Ozaki A; Kimura K; Takizawa T; Niitani H
    J Cancer Res Clin Oncol; 1982; 102(3):195-214. PubMed ID: 7061569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
    Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
    Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.